Sarepta Therapeutics Stock (SRPT)

Track Sarepta Therapeutics stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.

$18.67

▲ +0.86 (+4.76%) past year

Live · Updated Aug 26, 7:07 PM

Market Cap

$1.92B

P/E Ratio

—

1Y Return

+4.76%

EPS (TTM)

-$2.90

Read the latest TheStreet Pro articles mentioning Sarepta Therapeutics, including market roundups, portfolio updates, trade ideas, and investing analysis.

Articles

3 articles

trade-ideas These 3 Biotech Picks Can Combat Sarepta Losses After Unexpected Death
Bret JensenMay 9, 2025
SRPT ACAD
trade-ideas Sizing Up Sarepta Therapeutics for a Trade
Bret JensenAug 25, 2024
SRPT CRBP
trade-ideas Bearish Bets: 3 Nasdaq Stocks You Should Consider Shorting This Week
Bob LangJun 2, 2024
SRPT DKNG WDAY

Daily Diary Mentions

0 mentions

No diary mentions for SRPT yet.